A custom NGS panel covering 27 IARC carcinogenic HPV genotypes enabled detection of ccfHPV DNA across treatment strata and supported recurrence-risk modeling adjusted for stage and tumor size.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results